ClassID:

21627

A61K2123/00 - CPC Classification

Classification description:

Preparations for testing

Recent Application in this class:
#1
20260151522
2026-06-04

RADIOPHARMACEUTICAL MOFS FOR MEDICAL IMAGING

#2
20260151517
2026-06-04

SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF

#3
20260151516
2026-06-04

NEW PET TRACER FOR IMAGING OF THE FUNCTIONAL HEPATIC RESERVE

#4
20260151515
2026-06-04

SIGMA-1 COMPOUNDS, RADIOLIGANDS, AND RELATED METHODS OF USE

#5
20260144904
2026-05-28

Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds

#6
20260144903
2026-05-28

RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF

#7
20260139066
2026-05-21

ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

#8
20260137821
2026-05-21

PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF

#9
20260137820
2026-05-21

TRIFUNCTIONAL COMPOUND AND USE THEREOF

#10
20260137819
2026-05-21

FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF

#11
20260137818
2026-05-21

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#12
20260137812
2026-05-21

SYNTHETIC CANCER-SPECIFIC PROMOTERS

#13
20260131036
2026-05-14

CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF

#14
20260131035
2026-05-14

Mouse Anti-Human Monoclonal Antibody Against Glypican-3

#15
20260131034
2026-05-14

RADIOPHARMACEUTICALS TARGETING CARBONIC ANHYDRASE IX PROTEINS

#16
20260131033
2026-05-14

RADIOLABELED FRUCTOSE DERIVATIVES FOR MEDICAL IMAGING

#17
20260115337
2026-04-30

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#18
20260115334
2026-04-30

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

#19
20260115333
2026-04-30

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

#20
20260115332
2026-04-30

Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use

#21
20260115331
2026-04-30

PET IMAGING OF BACTERIAL INFECTION WITH A PET PROBE

#22
20260115314
2026-04-30

PREVENTION AND/OR TREATMENT OF CARDIAC DAMAGE

#23
20260108642
2026-04-23

USE OF EXOSOME, COMPLEX COMPRISING EXOSOME, TRACER, AND PREPARATION METHOD THEREOF

#24
20260108641
2026-04-23

PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF

#25
20260108640
2026-04-23

Peptide Composition for Cancer Approach and Diagnosis

#26
20260108637
2026-04-23

USES OF PSMA-TARGETING AND TSPO-TARGETING COMPOUNDS FOR EVALUATION OF INJURIES IN THE PERIPHERAL NERVOUS SYSTEM

#27
20260105599
2026-04-16

APPARATUS AND METHOD FOR MONITORING DISEASE

#28
20260103474
2026-04-16

NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES

#29
20260102527
2026-04-16

CD8b-BINDING POLYPEPTIDES

#30
20260097139
2026-04-09

GONADOTROPIN-RELEASING HORMONE RECEPTOR (GnRHR) TARGETED THERAPEUTICS AND USES THEREOF

#31
20260091148
2026-04-02

DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS

#32
20260091147
2026-04-02

METHOD FOR DETECTING INNATE IMMUNE ACTION IN VIVO USING GPR84-PET

#33
20260083866
2026-03-26

COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF

#34
20260083865
2026-03-26

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF

#35
20260077073
2026-03-19

GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF

#36
20260077072
2026-03-19

METHODS AND COMPOSITIONS FOR IMAGING MALIGNANCIES IN THE BONE MARROW

#37
20260077071
2026-03-19

Targeted Delivery of Theranostic Agents

#38
20260077070
2026-03-19

METHOD FOR INCREASING DISPERSION STABILITY OF NANOPARTICLES AS T1 MRI CONTRAST AGENT AND T1 MRI CONTRAST NANOPARTICLES

#39
20260076634
2026-03-19

IMAGING OF BRAIN LESIONS

#40
20260069728
2026-03-12

MULTI-TARGETING COMPOUND AND USE THEREOF

#41
20260069727
2026-03-12

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING AND USE THEREOF IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES

#42
20260069726
2026-03-12

ZWITTERIONIC COMPOUNDS AND USES THEREOF

#43
20260069725
2026-03-12

LIGAND COMPOUND TARGETING PSMA ANTIGEN, AND CHELATE AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

#44
20260061085
2026-03-05

CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR, AND COMPLEX COMPRISING SAME AND USE THEREOF

#45
20260061084
2026-03-05

FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#46
20260061082
2026-03-05

PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED DEEP-TUMOR PENETRATION OF POLYMER NANODRUGS AND METHODS OF USE THEREOF

#47
20260053961
2026-02-26

HETERODIMER AND RADIOACTIVE MEDICAL USE THEREOF

#48
20260053960
2026-02-26

DIMERIC RADIOPHARMACEUTICALS, COMPOSITIONS THEREOF AND USES THEREOF

#49
20260053959
2026-02-26

METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES

#50
20260051027
2026-02-19

GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES

#51
20260048194
2026-02-19

RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS

#52
20260048156
2026-02-19

FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS

#53
20260047818
2026-02-19

LEAKY JOINT SYNDROME DIAGNOSTICS AND TREATMENTS

#54
20260042817
2026-02-12

PET TRACER FOR DETECTION OF TRANSFORMING GROWTH FACTOR BETA

#55
20260041799
2026-02-12

HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME

#56
20260041798
2026-02-12

RADIOPAQUE HYDROLYSABLE HYDROGELS AND METHODS OF TREATMENT USING SAME

#57
20260041797
2026-02-12

RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF

#58
20260034251
2026-02-05

Radiotracer Labeling and Administration Methods and System

#59
20260028414
2026-01-29

5T4 BINDING POLYPEPTIDES AND USES THEREOF

#60
20260027242
2026-01-29

PET RADIOLIGANDS FOR IMAGING GLUTAMINYL CYCLASE ACTIVITY

#61
20260022186
2026-01-22

CD73 (NT5E) TARGETING POLYPEPTIDES

#62
20260021212
2026-01-22

BRAND-NEW SKELETON 99MTC-FAPI DIAGNOSTIC PROBE AND USE THEREOF IN PREPARATION OF DRUG OR REAGENT FOR DIAGNOSING TUMORS

#63
20260014285
2026-01-15

POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF

#64
20260014284
2026-01-15

PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#65
20260007786
2026-01-08

COMPOUNDS FOR COATING OF NANOSTRUCTURES

#66
20260000794
2026-01-01

IN VIVO TRANSITION METAL DETECTION

#67
20260000793
2026-01-01

MYOCARDITIS-TARGETED RADIONUCLIDE MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#68
20250387522
2025-12-25

PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS

#69
20250387521
2025-12-25

THERANOSTIC FOR TREATING CANCER

#70
20250375544
2025-12-11

DUAL MODE RADIOTRACER AND -THERAPEUTICS

#71
20250375540
2025-12-11

FIBROBLAST ACTIVATION PROTEIN TARGETING PRECURSOR AND RADIOTRACER

#72
20250360236
2025-11-27

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS

#73
20250360235
2025-11-27

RADIOLABELLING KIT AND METHOD FOR RADIOLABELLING

#74
20250360233
2025-11-27

Central Neurodegeneration Imaging Agent and Method of Preparing the Same

#75
20250352676
2025-11-20

N-Cyclopropyl-1-(4-(4-(Fluoro-18f)Phenyl)Pyrimidin-5-Yl)-N-Methylpiperidine- 4-Carboxamide and Uses in PET Imaging

#76
20250352653
2025-11-20

NEURON TARGETED 2-DEOXYGLUCOSE DENDRIMER FOR IMAGING AND TREATMENT OF NEUROLOGICAL DISEASES

#77
20250345468
2025-11-13

COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER

#78
20250340662
2025-11-06

BINDING PROTEIN

#79
20250340649
2025-11-06

SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF

#80
20250340637
2025-11-06

CD3 TARGETING ANTIBODIES AND USES THEREOF

#81
20250340633
2025-11-06

HUMAN ANTIBODIES AND USES THEREOF

#82
20250340562
2025-11-06

CHROMANE IMAGING LIGANDS

#83
20250339571
2025-11-06

RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER

#84
20250339569
2025-11-06

CARBONIC ANHYDRASE IX LIGANDS

#85
20250339568
2025-11-06

PRECURSOR AND RADIOTRACER FOR NEUROENDOCRINE THERANOSTICS

#86
20250339567
2025-11-06

COMPOUNDS WITH IMPROVED PHARMACOKINETICS FOR IMAGING AND THERAPY OF CANCER

#87
20250339565
2025-11-06

METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS

#88
20250339473
2025-11-06

ANTITUMOR AGENT, IMAGE GENERATION METHOD, BACTERIUM, AND PRODUCTION METHOD

#89
20250332300
2025-10-30

HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

#90
20250332296
2025-10-30

ZWITTERIONIC METAL CHELATORS

#91
20250332295
2025-10-30

ZWITTERIONIC METAL CHELATORS

#92
20250332290
2025-10-30

PSMA-TARGETING LIGANDS FOR MULTIMODAL APPLICATIONS

#93
20250325715
2025-10-23

RADIOLABELED LIPOSOMES AND METHODS OF USE FOR TREATING LEPTOMENINGEAL METASTASES

#94
20250325713
2025-10-23

DISEASE-TARGETED IMAGING AGENTS

#95
20250325711
2025-10-23

COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2

#96
20250325675
2025-10-23

APTAMER, CONJUGATE, COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF

#97
20250319215
2025-10-16

UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS)

#98
20250319213
2025-10-16

FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS

#99
20250312585
2025-10-09

SYSTEMS AND METHODS FOR IMPROVED TRANSPORT AND DISTRIBUTION OF AGENTS IN AND CHARACTERIZATION OF BIOLOGICAL TISSUE

#100
20250312500
2025-10-09

RADIOPHARMACEUTICALS WITH HIGH STABILITY AND RADIOLABELING EFFICIENCY AND THERANOSTIC KIT COMPRISING SAID RADIOPHARMACEUTICALS

#101
20250303005
2025-10-02

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED RENAL CLEARANCE

#102
20250296971
2025-09-25

GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS

#103
20250296959
2025-09-25

B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF

#104
20250295818
2025-09-25

MICROFLUIDIC PREPARATION OF DUAL-PHASE NANODROPLETS WITH FLUORINATED COMPOUNDS

#105
20250288611
2025-09-18

ICAM-1 TARGETED CAR CONSTRUCTS AND METHODS OF TREATMENT

#106
20250281633
2025-09-11

HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES

#107
20250276018
2025-09-04

CAR CONSTRUCTS AND METHODS OF TREATMENT

#108
20250269074
2025-08-28

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#109
20250269073
2025-08-28

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#110
20250262336
2025-08-21

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#111
20250242034
2025-07-31

PHOSPHORAMIDATE-BASED PSMA-TARGETED SMALL-MOLECULE DRUG CONJUGATES

#112
20250236680
2025-07-24

ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF

#113
20250235567
2025-07-24

AGENTS FOR TREATMENT OF ENDOMETRIOSIS AND OTHER BENIGN GYNECOLOGICAL NEOPLASMS

#114
20250235566
2025-07-24

TRISLINKER-CONJUGATED DIMERIC LABELING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM

#115
20250235562
2025-07-24

USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING

#116
20250228984
2025-07-17

Metallophore-Radionuclide Complex as Nuclear Imaging Contrast Agents

#117
20250228983
2025-07-17

PROBES FOR CELLULAR SENESCENCE

#118
20250222146
2025-07-10

Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof

#119
20250222145
2025-07-10

TRACER COMPOSITION FOR RADIOACTIVE PET DIAGNOSIS, INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF

#120
20250222143
2025-07-10

TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR

#121
20250213736
2025-07-03

SCISSION-ENHANCED NUCLEAR IMAGING AND TREATMENT

#122
20250205372
2025-06-26

RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT

#123
20250195702
2025-06-19

RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS

#124
20250186635
2025-06-12

GLOBULAR NANOSTRUCTURES HAVING AN ANCHORING LAYER

#125
20250186634
2025-06-12

METHODS OF TREATING SMALL CELL LUNG CANCER

#126
20250186629
2025-06-12

GLOBULAR NANOSTRUCTURES

#127
20250186607
2025-06-12

ONE-STEP SUPRAMOLECULAR MULTIFUNCTIONAL COATING ON PLANT VIRUS NANOPARTICLES FOR BIOIMAGING AND THERAPEUTIC APPLICATIONS

#128
20250177579
2025-06-05

NOVEL COMPOUND, a-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF

#129
20250161505
2025-05-22

CD206 Targeted Peptide Conjugates and Methods of Using the Same

#130
20250161504
2025-05-22

RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#131
20250161497
2025-05-22

IMPLANTS AND BIODEGRADABLE TISSUE MARKERS

#132
20250152759
2025-05-15

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST MET

#133
20250152758
2025-05-15

PROBE FOR NUCLEAR MEDICAL TESTING

#134
20250144255
2025-05-08

IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION UTILIZING GENETIC CODE EXPANSION

#135
20250144254
2025-05-08

ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF

#136
20250144249
2025-05-08

METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS

#137
20250135050
2025-05-01

IODIDE NANOPARTICLES AND COMPOSITIONS OF METHODS OF USE THEREOF

#138
20250135049
2025-05-01

Methods for Biological Material Labeling and Medical Imaging

#139
20250135047
2025-05-01

IMPROVED ALUMINUM FLUORIDE RADIOSYNTHESIS OF [18F]DK222

#140
20250135046
2025-05-01

CHOLECYSTOKININ B RECEPTOR-TARGETED COMPLEX AND A CONTRAST AGENT THEREOF

#141
20250135045
2025-05-01

FAP-ALPHA SPECIFIC TUMOR DIAGNOSTIC IMAGING AGENT

#142
20250135044
2025-05-01

MULTIVALENT GLYCO-COMPLEX, IMAGING AGENT AND USES THEREOF

#143
20250135043
2025-05-01

DUAL-TARGETING COMPOUND FOR FIBROBLAST ACTIVATION PROTEIN (FAP) AND INTEGRIN avB3, PREPARATION METHOD THEREFOR AND USE THEREOF

#144
20250129153
2025-04-24

CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS

#145
20250127941
2025-04-24

DETECTION AND LOCALIZATION OF INTERNAL BLEEDING

#146
20250127938
2025-04-24

THERAGNOSTIC FOLATE CONJUGATES

#147
20250122280
2025-04-17

ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF

#148
20250121100
2025-04-17

COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING

#149
20250114489
2025-04-10

MASKED IL12 PROTEIN

#150
20250114486
2025-04-10

MARKED FATTY ACID DERIVATIVE, PRECURSOR COMPOUND THEREOF, AND USE THEREOF IN CONTRAST AGENT

#151
20250108139
2025-04-03

PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE

#152
20250108137
2025-04-03

APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES

#153
20250101109
2025-03-27

ANTI-B7-H3 COMPOUNDS AND METHODS OF USE

#154
20250099635
2025-03-27

IIMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES

#155
20250090700
2025-03-20

HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE

#156
20250090699
2025-03-20

FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

#157
20250090698
2025-03-20

SMALL MOLECULE INHIBITORS FOR EARLY DIAGNOSIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN CANCERS AND NEURODEGENERATIVE DISEASES

#158
20250090697
2025-03-20

ZWITTERIONIC METAL CHELATORS

#159
20250090574
2025-03-20

BIOMATERIAL COMPRISING POLY(ITACONATE-CO-DODECANEDIOL)

#160
20250082797
2025-03-13

Methods for In Vivo Tracking of Cells

#161
20250082795
2025-03-13

COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF

#162
20250082792
2025-03-13

ZWITTERIONIC METAL CHELATORS

#163
20250064991
2025-02-27

COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF

#164
20250064990
2025-02-27

METHODS OF SCREENING FOR VMAT2 INHIBITORS

#165
20250059280
2025-02-20

METHODS OF TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE

#166
20250057999
2025-02-20

GLUTAMIC ACID -UREA COMPOUND, PREPARATION METHOD AND USE THEREOF, NUCLIDE-TARGETED PROBE, PREPARATION METHOD AND USE THEREOF, AND PHARMACEUTICAL COMPOSITION

#167
20250057994
2025-02-20

LABELED COMPOUNDS AND CALCIUM SENSING RECEPTOR LIGANDS FOR IMAGING AND USES THEREOF

#168
20250049972
2025-02-13

METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION

#169
20250049968
2025-02-13

THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE

#170
20250049967
2025-02-13

PET TRACERS FOR VISUALIZING GABAA GAMMA1 RECEPTORS

#171
20250049962
2025-02-13

NEAR-INFRARED FLUORESCENT CONTRAST BIOIMAGING AGENTS FOR IMAGING OF SENTINEL LYMPH NODES

#172
20250041462
2025-02-06

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#173
20250041461
2025-02-06

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#174
20250041410
2025-02-06

Formulations Comprising a SADA Complex

#175
20250032619
2025-01-30

MICROFLUIDIC PREPARATION OF FLUOROCARBON CROSS-LINKED VESICLES

#176
20250026844
2025-01-23

ANTI-BCMA NANOBODY AND USE THEREOF

#177
20250025585
2025-01-23

HER2 AFFIBODY RADIONUCLIDE MARKER COMPOSITION AND APPLICATION THEREOF

#178
20250025582
2025-01-23

LIGANDS AND THEIR USE

#179
20250025581
2025-01-23

Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe

#180
20250025569
2025-01-23

TISSUE-SPECIFIC IMAGING AND THERAPEUTIC AGENTS TARGETING PROTEINS EXPRESSED ON MUSCLE CELL SURFACE

#181
20250025426
2025-01-23

SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES

#182
20250009918
2025-01-09

NANOPARTICLES FOR POTENTIATING EFFECTS OF RADIATION THERAPY ON ANTI-CANCER IMMUNOTHERAPY

#183
20250009913
2025-01-09

COMPOUNDS FOR USE IN NON-COVALENT SCAFFOLD AND METHODS RELATED THERETO

#184
20250009911
2025-01-09

DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN

#185
20250009908
2025-01-09

Fluorescently Labeled Immunoglobulin Single Variable Domains

#186
20240424153
2024-12-26

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

#187
20240424152
2024-12-26

AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION

#188
20240415989
2024-12-19

RADIOLABELED COMPOUND, AND PRECURSOR COMPOUND THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#189
20240408247
2024-12-12

NON-PEPTIDE TARGETED THERAPEUTICS AND USES THEREOF

#190
20240390531
2024-11-28

NOVEL ANTIBODY SEQUENCES FOR DIAGNOSTICS AND THERAPEUTICS

#191
20240390530
2024-11-28

GRANZYME B DIRECTED IMAGING AND THERAPY

#192
20240390529
2024-11-28

DUAL-MODE PROBE FOR DETECTING HYDROGEN SULFIDE AND USE THEREOF

#193
20240382633
2024-11-21

RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES

#194
20240382632
2024-11-21

METHODS OF PREPARATION OF 18F LABELLED SILYL-FLUORIDE COMPOUNDS

#195
20240382629
2024-11-21

HETEROBIVALENT AND HOMOBIVALENT AGENTS TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA AND/OR PROSTATE-SPECIFIC MEMBRANE ANTIGEN

#196
20240382627
2024-11-21

NON-METALLIC TEMPERATURE-RESPONSIVE COMPOSITE FOR MAGNETIC RESONANCE IMAGING (MRI), AND PREPARATION METHOD AND USE THEREOF

#197
20240371538
2024-11-07

3D PRINTING OF SOLID-STATE PHANTOMS

#198
20240366815
2024-11-07

TREATMENT OF PROSTATE CANCER WITH RADIOLABELED ANTIBODIES TARGETING CDCP1

#199
20240366811
2024-11-07

RADIONUCLIDE LABELED POLYPEPTIDE CONJUGATES AND USES THEREOF

#200
20240366807
2024-11-07

RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN

#201
20240358867
2024-10-31

REAGENTS FOR SITE-SPECIFIC LABELING OF PROTEINS WITH RADIOHALOGENS, AND METHODS OF MAKING AND USING THE SAME

#202
20240358865
2024-10-31

QUINOLINYL AND PRIDINYL CONTAINING COMPOUNDS TARGETING ON ALPHA-SYNUCLEIN FOR NEUROLOGICAL DISEASES

#203
20240358861
2024-10-31

COMPOSITIONS AND METHODS OF FLUORESCEIN SODIUM FOR EARLY DIAGNOSIS OF CERVICAL CANCER

#204
20240342322
2024-10-17

Netrin-1 detection, companion test and therapy based on radiations

#205
20240336632
2024-10-10

NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF

#206
20240325574
2024-10-03

EXTRADOMAIN B FIBRONECTIN TARGETING PEPTIDES AND DERIVATIVES FOR CANCER IMAGING AND THERAPY

#207
20240316225
2024-09-26

SYNTHETIC CYCLIC PEPTIDE MIMETICS

#208
20240316224
2024-09-26

CARBONIC ANHYDRASE IX TARGETING AGENTS AND METHODS

#209
20240307564
2024-09-19

ANTI-CLDN18.2 ANTIBODY CONJUGATES

#210
20240307562
2024-09-19

ANTI-oxMIF RADIOIMMUNOCONJUGATE

#211
20240299595
2024-09-12

CANCER THERANOSTIC COMPOSITIONS COMPRISING BIGUANIDE COMPLEXES OF GROUP 7 TRANSITION METALS AND USES THEREOF

#212
20240298987
2024-09-12

Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same

#213
20240285815
2024-08-29

TRUNCATED EVANS BLUE MODIFIED FIBROBLAST ACTIVATION PROTEIN INHIBITOR, PREPARATION METHOD AND APPLICATION THEREOF

#214
20240277878
2024-08-22

RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF

#215
20240277874
2024-08-22

FLUORESCENCE-MAGNETIC RESONANCE DUAL-MODALITY CONTRAST AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF

#216
20240261445
2024-08-08

PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES

#217
20240261442
2024-08-08

METHOD TO ASSESS NODAL DISEASE USING IRON OXIDE NANOPARTICLES IN MAGNETIC RESONANCE IMAGING

#218
20240252693
2024-08-01

FOLATE RECEPTOR-TARGETED RADIOTHERAPEUTIC AGENTS AND THEIR USE

#219
20240238458
2024-07-18

COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF

#220
20240238454
2024-07-18

LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION

#221
20240216554
2024-07-04

RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER

#222
20240216553
2024-07-04

DEVELOPMENT OF CD163 TARGETING AGENT FOR IMAGING AND THERAPY

#223
20240216551
2024-07-04

RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN

#224
20240207460
2024-06-27

HER2 AFFIBODY 99MTC MARKER COMPOSITION AND APPLICATION THEREOF

#225
20240189460
2024-06-13

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#226
20240182586
2024-06-06

Site-Specific Modification of Glycoproteins Through Transglutaminase-Mediated Conjugation

#227
20240180849
2024-06-06

IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY

#228
20240174608
2024-05-30

COMPOUNDS FOR BRAIN IMAGING

#229
20240173441
2024-05-30

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#230
20240173440
2024-05-30

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#231
20240172953
2024-05-30

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#232
20240165282
2024-05-23

CONFORMATIONAL CONSTRAINED SOMATOSTATIN RECEPTOR 3 PEPTIDE LIGANDS AND THEIR CONJUGATES AND USES THEREOF

#233
20240165278
2024-05-23

GRANZYME B DIRECTED IMAGING AND THERAPY

#234
20240165127
2024-05-23

CONTRAST AGENT FOR DIAGNOSIS OF VASCULAR DISEASE CONTAINING GADOLINIUM-BASED COMPOUND AS ACTIVE INGREDIENT AND SYNTHESIS METHOD THEREFOR

#235
20240156996
2024-05-16

BIOCOMPATIBLE RADIONUCLIDE-CONTAINING COMPOSITIONS AND METHODS OF USE

#236
20240148961
2024-05-09

RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS

#237
20240148918
2024-05-09

Loading of Alginate Microspheres

#238
20240148916
2024-05-09

BIVALENT FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS

#239
20240139350
2024-05-02

RADIOACTIVELY LABELED LIGAND FOR FIBROBLAST ACTIVATION PROTEIN-ALPHA IMAGING AGENT AND PREPARATION METHOD THEREFOR

#240
20240131207
2024-04-25

NUCLIDE-LABELED INHIBITORY PEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#241
20240131203
2024-04-25

FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#242
20240123099
2024-04-18

Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders

#243
20240116978
2024-04-11

METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS

#244
20240115740
2024-04-11

PRECISE LABELING OF PROTEIN SCAFFOLDS WITH CARGO FOR USE IN BIOMEDICAL APPLICATIONS

#245
20240100204
2024-03-28

COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY

#246
20240091390
2024-03-21

IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY

#247
20240082435
2024-03-14

Solid phase synthesis of glutamate-urea-lysine derived (GUL derived) prostate-specific membrane antigen (PSMA) targeting conjugates and their use as precursors for therapeutic and/or diagnostic agents

#248
20240066157
2024-02-29

Molecular imaging complex for positron emission tomography

#249
20240033366
2024-02-01

FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOF

#250
20240018110
2024-01-18

RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN

#251
20230414794
2023-12-28

PSMA INHIBITOR, COMPOUND AND APPLICATION

#252
20230406847
2023-12-21

LIGANDS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) CONTAINING HETEROAROMATIC LINKER BUILDING BLOCKS

#253
20230405156
2023-12-21

METHODS OF DIAGNOSING AND PROGNOSING CANCERS OF THE HEAD AND NECK

#254
20230391851
2023-12-07

ANTIBODIES

#255
20230390421
2023-12-07

Truncated Evans Blue modified fibroblast activation protein inhibitor, preparation method and application thereof

#256
20230372551
2023-11-23

RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE

#257
20230364277
2023-11-16

E-SELECTIN TARGETING AGENTS

#258
20230355814
2023-11-09

BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF

#259
20230346989
2023-11-02

FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING

#260
20230302043
2023-09-28

BIOMATERIAL COMPRISING POLY(ITACONATE-CO-CITRATE-CO-OCTANEDIOL)

#261
20230248853
2023-08-10

Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals

#262
20230201383
2023-06-29

PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING

#263
20230122957
2023-04-20

PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY

#264
20220402951
2022-12-22

RADIOISOTOPE LABELED COMPOUND FOR IMAGING OR TREATMENT OF PROSTATE CANCER

#265
20220401586
2022-12-22

CARBON QUANTUM DOTS AND USES THEREOF

#266
20220370650
2022-11-24

FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF

#267
20220296733
2022-09-22

Lipid microbubbles and process of making thereof

#268
20220211879
2022-07-07

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

#269
20220143230
2022-05-12

Bifunctional do2pa derivatives, chelates with metallic cations and use thereof

#270
20220143225
2022-05-12

ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT

#271
20220133919
2022-05-05

ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD

#272
20220125954
2022-04-28

IMPLANTS AND BIODEGRADABLE TISSUE MARKERS

#273
20220024896
2022-01-27

Tau PET imaging ligands

#274
20220008569
2022-01-13

PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS

#275
20220001036
2022-01-06

Half-curcuminoids as amyloid-beta pet imaging agents

#276
20220001035
2022-01-06

Half-curcuminoids as amyloid-β PET imaging agents

#277
20210268127
2021-09-02

ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE AND PEPTIDES THEREFOR

#278
20210220490
2021-07-22

Conformational restriction of cyanine fluorophores in far-red and near-IR range

#279
20210069353
2021-03-11

Implant and biodegradable tissue marker compositions and methods

#280
20210040326
2021-02-11

AZACYANINE DYES AND USE THEREOF

#281
20210024468
2021-01-28

8-hydroxyquinoline derivatives as diagnostic and therapeutic agents

#282
20210008100
2021-01-14

Biomaterial comprising poly(itaconate-co-citrate-co-octanediol)

#283
20210000981
2021-01-07

CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE

#284
20200399718
2020-12-24

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

#285
20200390914
2020-12-17

Method for labeling radioisotope, radiolabeling compounds using quinone compound and kit comprising the same for labeling radioisotope

#286
20200330617
2020-10-22

Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound

#287
20200330613
2020-10-22

SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF

#288
20200297876
2020-09-24

PSMA ligands for imaging and endoradiotherapy

#289
20200222564
2020-07-16

Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof

#290
20200209263
2020-07-02

INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND TREATMENT

#291
20200206367
2020-07-02

Echolucent implant compositions and methods

#292
20200206366
2020-07-02

Echolucent implant composition and methods

#293
20200206365
2020-07-02

Echolucent implant compositions and methods

#294
20200197544
2020-06-25

JCV IMAGING METHODS AND COMPOSITIONS

#295
20200197539
2020-06-25

Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans

#296
20200179536
2020-06-11

Conformational restriction of cyanine fluorophores in far-red and near-IR range

#297
20200157099
2020-05-21

3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents

#298
20200129646
2020-04-30

Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof

#299
20200085981
2020-03-19

Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms

#300
20200085979
2020-03-19

PRECISION MEDICINE THERANOSTICS AND DIAGNOSTICS A COMBINATION THEREOF